U.S. markets close in 4 hours 46 minutes

Teva Pharmaceutical Industries Limited (TEVA)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
8.91-0.08 (-0.89%)
As of 11:13AM EDT. Market open.
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
As of Date: 9/18/2021
Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 7

Trading Information

Stock Price History

Beta (5Y Monthly) 1.45
52-Week Change 30.45%
S&P500 52-Week Change 335.11%
52 Week High 313.30
52 Week Low 38.24
50-Day Moving Average 39.52
200-Day Moving Average 310.20

Share Statistics

Avg Vol (3 month) 38.52M
Avg Vol (10 day) 36.65M
Shares Outstanding 51.1B
Implied Shares Outstanding 6N/A
Float 1.1B
% Held by Insiders 11.05%
% Held by Institutions 151.07%
Shares Short (Aug 30, 2021) 423.29M
Short Ratio (Aug 30, 2021) 43.52
Short % of Float (Aug 30, 2021) 4N/A
Short % of Shares Outstanding (Aug 30, 2021) 42.11%
Shares Short (prior month Jul 29, 2021) 433.24M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Dec 11, 2017
Ex-Dividend Date 4Nov 26, 2017
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Jun 29, 2021


Profit Margin -23.98%
Operating Margin (ttm)18.13%

Management Effectiveness

Return on Assets (ttm)3.55%
Return on Equity (ttm)-29.63%

Income Statement

Revenue (ttm)16.32B
Revenue Per Share (ttm)14.87
Quarterly Revenue Growth (yoy)1.00%
Gross Profit (ttm)7.73B
Net Income Avi to Common (ttm)-3.92B
Diluted EPS (ttm)-3.57
Quarterly Earnings Growth (yoy)47.90%

Balance Sheet

Total Cash (mrq)2.44B
Total Cash Per Share (mrq)2.21
Total Debt (mrq)25.58B
Total Debt/Equity (mrq)226.12
Current Ratio (mrq)1.01
Book Value Per Share (mrq)9.36

Cash Flow Statement

Operating Cash Flow (ttm)451M
Levered Free Cash Flow (ttm)1.3B